Knowledge Center
Patent / Jan 01, 1975
Doxycycline alkali metaphosphate complexes
Source:
GB 1463726
Treatment of doxycycline (I, .alpha.-6-desoxy-5-hydroxytetracycline) with HPO3 (mole ratio I-HPO3 = 1-5:1) in an inert medium (e.g., CHCl3 or MeOH), then treating the excess HPO3 with methanolic or ethanolic NaOH or KOH gave a doxycycline alkali polyphosphate complex x I.y MPO3.z HPO3 [M = Na or K, x = 1-5, y = 1-5, z = 1-5 (y+z = 6, x .ltoreq. z], the soly. of which is such that, when taken internally, it maintains a more even and higher oxycycline concn. in blood than the known doxycycline hyclate.
Also in the Knowledge Center
/ Jan 26, 2023
Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Development by Design: Hovione’s Approach to Spray Drying Process Development
Read more
Scientific Article
/ Feb 22, 2017
Webinar - Physical Characterization of Drugs: avoiding surprises during late development
Read more
Scientific Article